ADAM19 antibody

Este producto es parte de ADAM19 - ADAM metallopeptidase domain 19
Product Graph
Contáctenos para saber el precio

Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.

935106861
info@markelab.com
name
ADAM19 antibody
category
Primary Antibodies
provider
FineTest
reference
FNab00140
tested applications
ELISA, WB, IP

Description

Participates in the proteolytic processing of beta-type neuregulin isoforms which are involved in neurogenesis and synaptogenesis, suggesting a regulatory role in glial cell. Also cleaves alpha-2 macroglobulin. May be involved in osteoblast differentiation and/or osteoblast activity in bone(By similarity).

Documents del producto

Instrucciones
Descargar
Data sheet
Descargar

Product specifications

Category
Primary Antibodies
Immunogen Target
ADAM metallopeptidase domain 19(meltrin beta) (ADAM19)
Host
Rabbit
Reactivity
Human, Mouse
Recommended Dilution
WB: 1:200-1:1000; IP: 1:200-1:1000
Clonality
polyclonal
Conjugation
Unconjugated
Isotype
IgG
Observed MW
70 kDa
Purity
≥95% as determined by SDS-PAGE
Purification
Immunogen affinity purified
Size 1
100µg
Form
liquid
Tested Applications
ELISA, WB, IP
Storage
PBS with 0.02% sodium azide and 50% glycerol pH 7.3, -20℃ for 12 months(Avoid repeated freeze / thaw cycles.)
UniProt ID
Q9H013
Gene ID
8728
Alias
MLTNB, MADDAM,Meltrin Beta,FKSG34,adam-19
Background
Antibody anti-ADAM19
Status
RUO
Note
Mol. Weight 70 kDa

Descripción

ADAM19, or ADAM metallopeptidase domain 19, is a member of the ADAM (a disintegrin and metalloproteinase) family of proteins. These proteins are characterized by their multidomain structure, which includes a metalloproteinase domain responsible for enzymatic activity, a disintegrin domain involved in cell adhesion, and other functional domains such as cysteine-rich and EGF-like domain. ADAM19 is involved in various cellular processes, including cell adhesion, migration, and proteolysis. It has been implicated in the regulation of cell-cell and cell-matrix interactions, as well as in the proteolytic processing of membrane-bound proteins. The exact substrates and biological functions of ADAM19 are still being elucidated, but it is thought to play roles in development, tissue remodeling, and possibly in diseases. ADAM19 has been studied in the context of development, particularly in the central nervous system (CNS). It is expressed in regions of the brain and spinal cord during embryonic development, suggesting potential roles in neural development and circuit formation. Studies in animal models have shown that ADAM19 knockout mice exhibit abnormalities in neural tube closure, indicating its importance in early embryonic development.While the specific roles of ADAM19 in disease pathogenesis are not fully understood, alterations in its expression and activity have been reported in various pathological conditions. Dysregulation of ADAM19 has been observed in cancer, where it may contribute to tumor progression and metastasis by affecting cell adhesion and migration. Additionally, ADAM19 expression has been associated with certain cardiovascular diseases and inflammatory disorders, although further research is needed to fully elucidate its contributions to these conditions.

Related Products

FNab00140

ADAM19 antibody

Participates in the proteolytic processing of beta-type neuregulin isoforms which are involved in neurogenesis and synaptogenesis, suggesting a regulatory role in glial cell. Also cleaves alpha-2 macroglobulin. May be involved in osteoblast differentiation and/or osteoblast activity in bone(By similarity).

Ver Producto
abx037566

ADAM Metallopeptidase Domain 19 (ADAM19) Antibody

Rabbit Polyclonal against the ADAM19 protein.

Ver Producto
abx038255

ADAM Metallopeptidase Domain 19 (ADAM19) Antibody

Rabbit Polyclonal against the ADAM19 protein.

Ver Producto